Marizyme, Inc.
MRZM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $33 | $151 |
| % Growth | – | -100% | -78.2% | – |
| Cost of Goods Sold | $211 | $223 | $219 | $267 |
| Gross Profit | -$211 | -$223 | -$186 | -$116 |
| % Margin | – | – | -566.4% | -77.4% |
| R&D Expenses | $344 | $312 | $322 | $387 |
| G&A Expenses | $563 | $759 | $598 | $6,734 |
| SG&A Expenses | $902 | $1,156 | $963 | $7,545 |
| Sales & Mktg Exp. | $339 | $397 | $364 | $811 |
| Other Operating Expenses | $109 | $121 | $110 | $14,462 |
| Operating Expenses | $1,355 | $1,589 | $1,395 | $22,395 |
| Operating Income | -$1,355 | -$1,589 | -$1,372 | -$22,292 |
| % Margin | – | – | -4,175.9% | -14,806.2% |
| Other Income/Exp. Net | -$605 | -$2,483 | -$4,854 | $12,527 |
| Pre-Tax Income | -$1,960 | -$4,073 | -$6,226 | -$9,766 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,960 | -$4,073 | -$6,226 | -$9,766 |
| % Margin | – | – | -18,949.9% | -6,486.4% |
| EPS | -0.015 | -0.031 | -0.047 | -0.19 |
| % Growth | 51.8% | 34.5% | 75.2% | – |
| EPS Diluted | -0.015 | -0.031 | -0.047 | -0.19 |
| Weighted Avg Shares Out | 131,793 | 131,793 | 131,793 | 45,473 |
| Weighted Avg Shares Out Dil | 131,793 | 131,793 | 131,793 | 45,473 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,105 | $3,438 | $4,162 | $7,697 |
| Depreciation & Amortization | $211 | $223 | $209 | $210 |
| EBITDA | -$644 | -$912 | -$1,855 | -$7,838 |
| % Margin | – | – | -5,646% | -5,205.7% |